Zoetis Inc. (FRA:ZOE)
109.84
-1.10 (-0.99%)
At close: Dec 1, 2025
Zoetis Revenue
Zoetis had revenue of $2.40B USD in the quarter ending September 30, 2025, with 0.50% growth. This brings the company's revenue in the last twelve months to $9.40B, up 2.68% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.40B
Revenue Growth
+2.68%
P/S Ratio
6.02
Revenue / Employee
$680.94K
Employees
13,800
Market Cap
48.24B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
| Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
| Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
| Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
| Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
| Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
| Dec 31, 2018 | 5.83B | 518.00M | 9.76% |
| Dec 31, 2017 | 5.31B | 419.00M | 8.57% |
| Dec 31, 2016 | 4.89B | 123.00M | 2.58% |
| Dec 31, 2015 | 4.77B | -20.00M | -0.42% |
| Dec 31, 2014 | 4.79B | 224.00M | 4.91% |
| Dec 31, 2013 | 4.56B | 225.00M | 5.19% |
| Dec 31, 2012 | 4.34B | 103.00M | 2.43% |
| Dec 31, 2011 | 4.23B | 651.00M | 18.17% |
| Dec 31, 2010 | 3.58B | 822.00M | 29.78% |
| Dec 31, 2009 | 2.76B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Deutsche Post AG | 84.05B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
Zoetis News
- 23 hours ago - 2 Stocks to Buy Near Their 52-Week Lows - The Motley Fool
- 5 days ago - Zoetis (ZTS) Gains EU Approval for Lenivia in Canine Osteoarthritis - GuruFocus
- 5 days ago - Zoetis (ZTS) Gains EU Approval for Canine Osteoarthritis Therapy Lenivia - GuruFocus
- 5 days ago - Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Business Wire
- 5 days ago - Zoetis Receives European Commission Marketing Authorization for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Wallstreet:Online
- 7 days ago - Paul Harris' Top Picks: FirstService, Zoetis & Adobe - BNN Bloomberg
- 10 days ago - Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Benzinga
- 10 days ago - Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Benzinga